Grand strategies and strategic actions in the pharmaceutical industry 2001–2002

Abstract

This paper explores the strategic actions realised by firms in the pharmaceutical industry during 2001 and 2002. The purpose was to develop an empirically derived categorisation of strategic actions and grand strategies from the behaviour of firms that could be used as the basis of a methodological framework for developing understanding of strategic change. Qualitative analysis was used to identify and categorise strategic actions implemented by pharmaceutical firms. Twenty-three grand strategies were identified and are described. Implications for further research in strategy development are discussed.

Acknowledgement

Information from Scrip was used with the permission of PJB Publications Ltd.

Notes

1. R. Coombs and J. Metcalfe, Innovation in Pharmaceutical Perspectives on the Co-ordination, Combination and Creation of Capabilies, Technology Analysis & Strategic Management, 14(3), 2002, pp. 261–271.

2. P. Allen, R. Ramlogan and S. Randles, Complex Systems and the Merger Process, Technology Analysis & Strategic Management, 14(3), 2002, pp. 315–329.

3. T. T. Jones and T. A. J. Cockerill, Structure and Performance of Industries (Oxford, Philip Allan Publishers Ltd, 1984).

4. H. Kettler, (ed) Consolidation and Competition in the Pharmaceutical Industry, (London, Office of Health Economics, 2001b).

5. R. Coombs and J. Metcalfe, Innovation in pharmaceutical perspectives on the co-ordination, combination and creation of capabilies, Technology Analysis & Strategic Management, 14(3), 2002, pp. 261–271.

6. PhRMA (Pharmacuetical Research and Manufacturers of America) Pharmaceutical Industry Profile: 2003 (WashiNgton, DC, PhRMA, 2003).

7. J. S. Bain, Barriers to New Competition (London, Oxford University Press, 1956).

8. E. S. Mason, Economic Concentration and the Monopoly Problem (Cambridge, Harvard University Press, 1959).

9. F. M. Scherer, Industrial Market Structure and Economic Performance (2nd edn) (Chicago, Rand McNally College Publishing Company, 1980).

10. H. T. Kettler, Competition Through Innovation, Innovation Through Competition (London, Office of Health Economics, 1997).

11. M. J. Cunningham, Genomics and proteomics. The new millennium of drug discovery and development, Journal of Pharmacological and Toxicological Methods, 44, 2000, pp. 291–300.

12. L. Orsenigo, F. Pammolli and M. Riccaboni, Technological change and network dynamics. Lessons from the pharmaceutical industry', Research Policy, 30, 2001, pp. 485–508.

13. R. Coombs and J. Metcalfe, Innovation in pharmaceutical perspectives on the co-ordination, combination and creation of capabilies, Technology Analysis & Strategic Management, 14(3), 2002, pp. 261–271.

14. T. T. Jones and T. A. J. Cockerill, Structure and Performance of Industries (Oxford, Philip Allan Publishers Ltd, 1984).

15. R. Balance, J. Pogany and H. Forstner, The World's Pharmaceutical Industries (Worcester, Billing and Sons Ltd, 1992).

16. T. Belcher and L. Nail, Integration problems and turnaround strategies in a cross-border merger. A clinical examination of the Pharmacia–Upjohn merger, International Review of Financial Analysis, 9(2), 2000, pp. 219–234.

17. Z. Griliches and I. M.Cockburn, Generics and the producer price index for pharmaceuticals, in: R. B. Helms (ed) Competitive Strategies In The Pharmaceutical Industry (Washington, DC, The AEI Press, 1996).

18. P. N. SubbaNarasihma, S. Ahmad and S. N. Mallya, Technological knowledge and firm performance of pharmaceutical firms, Journal of Intellectual Capital, 4(1), 2003, pp. 20–33.

19. R. Henderson and I. Cockburn, Measuring competence? Exploring firm effects in pharmaceutical research, Strategic Management Journal, 15, 1994, pp. 63–84.

20. I. Cockburn, R. Henderson and S. Stern, Untangling the origins of competitive advantage, Strategic Management Journal, 21, 2000, pp. 1123–1145.

21. A. D. James, The strategic management of mergers and acquisitions in the pharmaceutical industry: Developing a resource-based perspective, Technology Analysis & Strategic Management, 14(3), 2002, pp. 299–313.

22. A. D. James, The strategic management of mergers and acquisitions in the pharmaceutical industry: Developing a resource-based perspective, Technology Analysis & Strategic Management, 14(3), 2002, pp. 299–313.

23. P. Allen, R. Ramlogan and S. Randles, Complex systems and the merger process. Technology Analysis & Strategic Management, 14(3), 2002, pp. 315–329.

24. D. J. Bower, New technology supply networks in the global pharmaceutical industry, International Business Review, 2(1), 1993, pp. 83–95.

25. R. Henderson and I. Cockburn, Measuring competence? Exploring firm effects in pharmaceutical research, Strategic Management Journal, 15, 1994, pp. 63–84.

26. H. T. Kettler, Competition Through Innovation, Innovation Through Competition (London, Office of Health Economics, 1997).

27. V. Walsh and G. Lodorfos, Technological and organisational innovation in chemicals and related products, Technology Analysis & Strategic Management, 14(3), 2002, pp. 273–298.

28. Schmidt, S. and Ruhli, E. Prior strategy processes as a key to understanding mega-mergers: The Novartis case, European Management Journal, June, 2002, pp. 223–234.

29. I. M. Cockburn, R. M. Henderson and S. Stern, Untangling the origins of competitive advantage, Strategic Management Journal, 21, 2000, pp. 1123–1145.

30. J. Drews, Strategic choices facing the pharmaceutical industry: A case for innovation, DDT, 2(2), 1997, pp. 72–78.

31. H. T. Kettler, Competition Through Innovation, Innovation Through Competition, (London, Office of Health Economics, 1997).

32. R. Balance, J. Pogany and H. Forstner, The World's Pharmaceutical Industries (Worcester, Billing and Sons Ltd, 1992).

33. R. Balance, J. Pogany and H. Forstner, The World's Pharmaceutical Industries (Worcester, Billing and Sons Ltd, 1992).

34. J. Taggart, The World Pharmaceutical Industry (London, Routledge, 1993).

35. R. Henderson and I. M. Cockburn, The determinants of research productivity in ethical drug discovery, in: R. B. Helms (ed) Competitive Strategies in the Pharmaceutical Industry (Washington, DC, The AEI Press, 1996), pp. 167–193.

36. T. Jones, Foreword, in Evolution and Revolution How Genomics Will Change Healthcare, written by Tim Radford and edited by Bill Kirkness, (London, ABPI, 2001), pp. 4–5.

37. M. Bhandari, R. Garg, R. Glassman, P. C. Ma and R. W. Zemmel, Genetic revolution in healthcare, McKinsey Quarterly, 4, 1999, pp. 58–67.

38. A. Maynard and K. Bloor, Dilemma in regulation of the market for pharmaceuticals, Health Affairs, 22(3), 2003, pp. 31–38.

39. ABPI (Association of the British Pharmaceutical Industry). (2004). Wholehearted welcome for Judgement in Parallel Trade Case. Press release issued on January 6^th 2004. Accessed at www.abpi.org.uk/press (January 9th 2004).

40. WTO (World Trade Organization) (2003). Decision Removes Final Patent Obstacle To Cheap Drug Imports. Press released issued on 30th August 2003. Accessed at www.wto.org/english/news (January 9th 2004).

41. J. Kay, Foundations of Corporate Success How Business Strategies Add Value (Oxford, Oxford University Press, 1993), p. 9.

42. H. Mintzberg, B. Ahlstrand and J. Lampel, Strategy Safari: A Guided Tour Through the Wilds of Strategic Management, (3rd edn) (New York, The Free Press, 1998), p. 9).

43. D. Webb and A. Pettigrew, The temporal development of strategy: Patterns in the UK insurance industry, Organization Science, 10(5), 1999, pp. 601–621.

44. D. Miller and M. J. Chen, Sources and consequences of competitive inertia: A study of the United States airline industry, Administrative Science Quarterly, 39(1), 1994, pp. 1–23.

45. J. Taggart, The World Pharmaceutical Industry (London, Routledge, 1993).

46. J. Taggart, The World Pharmaceutical Industry (London, Routledge, 1993).

47. M. D. Miles, and A. M. Huberman, Qualitative Data Analysis: An Expanded Sourcebook (2nd edn) (London, Sage, 1994).

48. C. Robson, Real World Research (2nd edn) (Oxford, Blackwell, 2002).

49. W. Outhwaite, Realism and social science, in: M. Archer, et al. (eds) Critical Realism: EssentialReadings (London, Routledge, 1998) pp. 1–34.

50. N. Blaikie, Approaches to Social Enquiry (Cambridge, Polity Press, 1995), p. 58.

51. R. E. Boyatzis, Thematic Analysis and Code Development Transforming Qualitative Information (California, Sage, 1998).

52. K. A. Nuendorf, The Content Analysis Guidebook (California, Sage, 2002).

53. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

54. H. Viney, Identifying Strategic Content Among Former Public Utilities, Unpublished PhD. Thesis, Middlesex University Business School, London, 2001.

55. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

56. J. Child and D. Faulkner, Strategies of Co-operation, Managing Alliances, Networks and Joint Ventures (Oxford, Oxford University Press, 1998).

57. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

58. R. E. Boyatzis, Thematic Analysis and Code Development Transforming Qualitative Information (California, Sage, 1998).

59. M. D. Miles and A. M. Huberman Qualitative Data Analysis: An Expanded Sourcebook, (2nd edn), (London, Sage Publications, 1994).

60. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

61. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

62. J. A. Pearce II, Selecting among alternative grand strategies, California Management Review, XXIV(3), 1982, pp. 23–31.

63. J. A. Pearce II and R. B. Robinson Jr, Strategic Management Formulation, Implementation and Control (5th edn) (Illinois, Irwin, 1994).

64. A. M. Pettigrew, Management research after modernism, British Journal of Management, 12, 2001, S.61–S70.

65. J. A. Pearce II, Selecting among alternative grand strategies, California Management Review, XXIV(3), 1982, pp. 23–31.

66. J. A. Pearce II, Selecting among alternative grand strategies, California Management Review, XXIV(3), 1982, pp. 23–31.

67. J. S. Bain, Barriers to New Competition (London, Oxford University Press, 1956).

68. E. S. Mason, Economic Concentration and the Monopoly Problem (Cambridge, MA, Harvard University Press, 1959).

69. F. M. Scherer, Industrial Market Structure and Economic Performance (2nd edn) (Chicago, Rand McNally, 1980).

70. J. McGee and H. Thomas, Strategic groups—Theory, research and taxonomy, Strategic Management Journal, 7(2), 1986, pp. 141–160.

71. H. Thomas and N. Venkatraman, Research on strategic groups—Progress and prognosis, Journal of Management Studies, 25(6), 1988, pp. 537–555.

72. W. Astley and A. H. Van de Ven, Central perspectives and debates in organization theory, Administrative Science Quarterly, 28, 1983, pp. 245–273.

73. L. W. Hrebiniak and W. F. Joyce, Organisational adaptation: Strategic choice and environmental determinism, Administrative Science Quarterly, 30, 1985, pp. 336–349.

74. J. Child, Strategic Choice: The Perspective and its Contemporary Relevance, (Cambridge, Judge Institute of Management Studies, 1995).

75. M. T. Hannan and J. Freeman, The population ecology of organisations, in: D. S. Pugh, (ed) Organisation Theory—Selected Readings (Harmondsworth, UK, Penguin, 1997), pp. 184–222.

76. W. Astley and A. H. Van de Ven, Central perspectives and debates in organization theory, Administrative Science Quarterly, 28, 1983, pp. 245–273.

77. L. W. Hrebiniak and W. F. Joyce, Organisational adaptation: Strategic choice and environmental determinism, Administrative Science Quarterly, 30, 1985, pp. 336–349.

78. G. R. Carroll and M. T. Hannan (eds), Organisations in Industry Strategy, Structure and Selection (Oxford, Oxford University Press, 1995).

79. R. E. Hoskisson, M. A., Hitt, W. P. Wan, and D. Yiu, Theory and research in strategic management: Swings of a pendulum, Journal of Management, 25(3), 1999, pp. 417–456.

80. A.Y. Lewin and H. W. Volberda, Prolegomena on coevolution: A framework for research on strategy and new organizational forms, Organization Science, 10(5), 1999, pp. 519–534.

81. H. Thomas and T. Pollock, From I-O economics; S-C-P paradigm through Strategic groups to competence-based competition: Reflections on the puzzle of competitive strategy, British Journal of Management, 10, 1999, pp. 127–140.

82. H. Mintzberg and J. A. Waters, ‘Tracking Strategy in an Entrepreneurial Firm’, Academy of Management Journal, 25(3), 1982, pp. 465–499.

83. A. D. James, The strategic management of mergers and acquisitions in the pharmaceutical industry: Developing a resource-based perspective, Technology Analysis & Strategic Management, 14(3), 2002, pp. 299–313.